Abiraterone Acetate in Patients with Advanced Castrate Resistant Prostate Cancer: Initial Real Life Experience in 2 Cancer Units

MLA

Jamal Zekri, et al. “Abiraterone Acetate in Patients with Advanced Castrate Resistant Prostate Cancer: Initial Real Life Experience in 2 Cancer Units.” Journal of Analytical Oncology, vol. 5, Apr. 2016, pp. 42–46. EBSCOhost, https://doi.org/10.6000/1927-7229.2016.05.01.6.

APA

Jamal Zekri, Ayman Ramadan, Muthu Kumar, & Rasha Haggag. (2016). Abiraterone Acetate in Patients with Advanced Castrate Resistant Prostate Cancer: Initial Real Life Experience in 2 Cancer Units. Journal of Analytical Oncology, 5, 42–46. https://doi.org/10.6000/1927-7229.2016.05.01.6

Chicago

Jamal Zekri, Ayman Ramadan, Muthu Kumar, and Rasha Haggag. 2016. “Abiraterone Acetate in Patients with Advanced Castrate Resistant Prostate Cancer: Initial Real Life Experience in 2 Cancer Units.” Journal of Analytical Oncology 5 (April): 42–46. doi:10.6000/1927-7229.2016.05.01.6.